Table 1.
Experimental groups involved in analysis of hepatoprotective activity of silver nanoparticles
| Groups (6 animals each) |
Carbon tetrachloride mixed 1:1 with olive oil | R. apiculata leaf extract | R. apiculata-derived silver nanoparticles | Silymarin |
|---|---|---|---|---|
| I | - | - | - | - |
| II | 0.5 mL/kg body weight (BW) | - | - | - |
| III | 0.5 mL/kg BW | Low dose - 1.75 mg/kg BW | - | - |
| IV | 0.5 mL/kg BW | Medium dose - 2.5 mg/kg BW | - | - |
| V | 0.5 mL/kg BW | High dose - 3.25 mg/kg BW | - | - |
| VI | 0.5 mL/kg BW | - | Low dose - 1.75 mg/kg BW | - |
| VII | 0.5 mL/kg BW | - | Medium dose - 2.5 mg/kg BW | - |
| VIII | 0.5 mL/kg BW | - | High dose - 3.25 mg/kg BW | - |
| IX | 0.5 mL/kg BW | - | - | 20 mg/kg BW |